TY - JOUR
T1 - Difference between RP2 and RP3 phenotypes in X linked retinitis pigmentosa
AU - Flaxel, Christina J.
AU - Jay, Marcelle
AU - Thiselton, Dawn L.
AU - Nayudu, Mani
AU - Hardcastle, Alison J.
AU - Wright, Alan
AU - Bird, Alan C.
PY - 1999
Y1 - 1999
N2 - Aim - X linked retinitis pigmentosa (XLRP) has two genetic loci known as 'RP2' and 'RP3'. Clinical features reported to differentiate RP2 from RP3 include a higher prevalence of myopia and primary cone dysfunction in RP2, and late onset night blindness and tapetal reflex in RP3. Members from 14 XLRP families were examined in an attempt to verify these differences. Methods - 16 affected males and 37 females from 14 XLRP families assigned as either RP2 or RP3 by haplotype analysis and/or by heterogeneity analysis were examined. Members of all 14 families who were willing to participate but unavailable for examination were contacted and detailed interviews carried out. Results - No clear phenotypic differences were found that could be used to reliably differentiate RP2 from RP3 with respect to myopia and onset of night blindness. The tapetal reflex was also found to be present in carriers of both RP2 and RP3. Conclusions - XLRP is a heterogeneous class of rod degenerative disorders with no clear phenotypic differentiation between the two genetic loci RP2 and RP3. There is a continuum of clinical presentations which can be seen in both RP2 and RP3, but the features within a given family tend to be consistent. However, interfamilial variability is prevalent leading to a wide range of clinical presentations and more than one abnormal allele at each gene locus cannot be excluded.
AB - Aim - X linked retinitis pigmentosa (XLRP) has two genetic loci known as 'RP2' and 'RP3'. Clinical features reported to differentiate RP2 from RP3 include a higher prevalence of myopia and primary cone dysfunction in RP2, and late onset night blindness and tapetal reflex in RP3. Members from 14 XLRP families were examined in an attempt to verify these differences. Methods - 16 affected males and 37 females from 14 XLRP families assigned as either RP2 or RP3 by haplotype analysis and/or by heterogeneity analysis were examined. Members of all 14 families who were willing to participate but unavailable for examination were contacted and detailed interviews carried out. Results - No clear phenotypic differences were found that could be used to reliably differentiate RP2 from RP3 with respect to myopia and onset of night blindness. The tapetal reflex was also found to be present in carriers of both RP2 and RP3. Conclusions - XLRP is a heterogeneous class of rod degenerative disorders with no clear phenotypic differentiation between the two genetic loci RP2 and RP3. There is a continuum of clinical presentations which can be seen in both RP2 and RP3, but the features within a given family tend to be consistent. However, interfamilial variability is prevalent leading to a wide range of clinical presentations and more than one abnormal allele at each gene locus cannot be excluded.
UR - http://www.scopus.com/inward/record.url?scp=0032835398&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032835398&partnerID=8YFLogxK
U2 - 10.1136/bjo.83.10.1144
DO - 10.1136/bjo.83.10.1144
M3 - Article
C2 - 10502575
AN - SCOPUS:0032835398
SN - 0007-1161
VL - 83
SP - 1144
EP - 1148
JO - British Journal of Ophthalmology
JF - British Journal of Ophthalmology
IS - 10
ER -